|
Press Releases |
|
 |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Thursday, June 2, 2022 |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
more info >> |
|
Thursday, September 30, 2021 |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
Friday, July 31, 2020 |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
Friday, July 24, 2020 |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
Tuesday, October 22, 2019 |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Monday, October 21, 2019 |
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所(Institute of High Performance Computing)、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
Friday, June 28, 2019 |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
EdgePoint Towers Appoints Ravin Vickneswaran as Chief Operating Officer
Apr 7, 2025 03:06 HKT/SGT
|
|
|
2024年華泰證券營收創新高 累計分紅46.94億元
Apr 6, 2025 22:30 HKT/SGT
|
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
Apr 6, 2025 20:30 HKT/SGT
|
|
|
《周遊記3》開播 背後「隱藏玩家」巨星傳奇再造頂流綜藝IP
Apr 6, 2025 19:45 HKT/SGT
|
|
|
雲康集團2024年醫聯體共建業務及特檢項目收益佔比持續增長
Apr 6, 2025 18:27 HKT/SGT
|
|
|
Smart Lighting Expo and Spring Lighting Fair open today
Apr 6, 2025 16:55 HKT/SGT
|
|
|
ForexRova Debuts at International Forex Conference, Promises Smarter Gold Trading Solutions
Apr 5, 2025 19:00: JST
|
|
|
ForexRova Debuts at International Forex Conference, Promises Smarter Gold Trading Solutions
Apr 5, 2025 18:00 HKT/SGT
|
|
|
Connect Marketplace Hong Kong 2025 Concludes, Successfully Ushering in a New Era for MICE in the City
Apr 4, 2025 0:00 JST
|
|
|
JF SmartInvest Holdings Ltd Announces 2024 Annual Results
Apr 4, 2025 22:48 HKT/SGT
|
|
|
The India Market Entry Dilemma: What's Holding Manufacturers Back
Apr 4, 2025 22:08 HKT/SGT
|
|
|
3rd Future Cross Border Payments Summit, Dubai 2025: Trends Shaping the Future of Payments
Apr 4, 2025 21:15 HKT/SGT
|
|
|
CISO Indonesia 2025: Elevating Cybersecurity Strategies for a Resilient Digital Future
Apr 4, 2025 20:50 HKT/SGT
|
|
|
analytica Vietnam 2025 Opens Tomorrow: The Leading Laboratory Exhibition Returns to Vietnam
Apr 4, 2025 20:40 HKT/SGT
|
|
|
Kirin and Hitachi begin joint research on the creation of forest-based carbon credits
Apr 4, 2025 15:56 JST
|
|
|
|
More News >> |
|
|
|
|
|